Business
Directorate changes and board succession planning
Directorate changes and board succession planning.
About this update from Surgical Innovations Group Plc
[{"type":"text","content":"\n\nSurgical Innovations Group Plc\n(the \"Company\")\n \nDirectorate changes and board succession planning\n \nSurgical Innovations Group Plc (AIM: SUN), the designer, manufacturer and distributor of innovative technology for minimally invasive surgery, announces the appointment of Jonathan Glenn as Senior Independent Non-executive Director and Chairman-designate of the Company with immediate effect. \n \nJonathan is an experienced board director and chairman, with an excellent track record in the medical device sector. He is currently Non-executive Chairman of Tissue Regenix plc, and was formerly Group CEO of Consort Medical Plc from 2007 to 2020, where he oversaw the £230m acquisition of a European contract development and manufacturing organisation. Jonathan led the business as CEO until its acquisition for £505m in 2020. Jonathan is a member of the Institute of Chartered Accountants in England and Wales.\n \nHe joins the board in anticipation of the upcoming retirement of Professor Mike McMahon, the founder of the Company, who retires from the board at the Annual General Meeting of the Company expected to take place on 27 June 2023. \n \nFollowing an orderly handover process, Jonathan will succeed Nigel Rogers as Chairman upon announcement of the interim results expected in September 2023. Nigel has indicated his intention to remain on the board until an additional independent non-executive director has been appointed.\n \nChairman of the Company, Nigel Rogers, commented: \"It has been my great pleasure to lead the board since my appointment in 2015, and especially to work alongside Prof. Mike McMahon. As part of our planned succession arrangements, we are now delighted to have Jonathan joining us, and look forward to working with him to complete the transition in board composition for the next stage in the Company's evolution.\"\n \nA separate announcement will be made in due course giving formal notice of the Company's 2023 AGM.\n \nThe following information is disclosed pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies:\n \nJonathan Martin Glenn (aged 54) is currently, or has during the past five years, been a director of the following companies:\n \n\n\n\nCurrent directorships or partnerships\n\n\nPrevious directorships or partne...